Publications:

Distinct Binding Preferences between Ras and Raf Family Members and the Impact on Oncogenic Ras Signaling.

Molecular Cell

Terrell, Elizabeth M EM; Durrant, David E DE; Ritt, Daniel A DA; Sealover, Nancy E NE; Sheffels, Erin E; Spencer-Smith, Russell R; Esposito, Dominic D; Zhou, Yong Y; Hancock, John F JF; Kortum, Robert L RL; Morrison, Deborah K DK

Publication Date: 2019-12-19

Variant appearance in text: EGF: G466V

PubMed Link: 31606273

Variant Present in the following documents:

• Main text

View BVdb publication page

Treatment-associated TP53 DNA-binding domain missense mutations in the pathogenesis of secondary gliosarcoma.

Oncotarget

Pain, Margaret M; Wang, Huaien H; Lee, Eunjee E; Strahl, Maya M; Hamou, Wissam W; Sebra, Robert R; Zhu, Jun J; Yong, Raymund L RL

Publication Date: 2018-01-05

Variant appearance in text: EGF: G466V

PubMed Link: 29416795

Variant Present in the following documents:

• Main text
• oncotarget-09-2603.pdf

View BVdb publication page

Gallic acid inhibition of Src-Stat3 signaling overcomes acquired resistance to EGF receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer.

Oncotarget

Phan, Ai N H AN; Hua, Tuyen N M TN; Kim, Min-Kyu MK; Vo, Vu T A VT; Choi, Jong-Whan JW; Kim, Hyun-Won HW; Rho, Jin Kyung JK; Kim, Ki Woo KW; Jeong, Yangsik Y

Publication Date: 2016-08-23

Variant appearance in text: EGF: G466V

PubMed Link: 27419630

Variant Present in the following documents:

• Main text

View BVdb publication page

Effects of Raf dimerization and its inhibition on normal and disease-associated Raf signaling.

Molecular Cell

Freeman, Alyson K AK; Ritt, Daniel A DA; Morrison, Deborah K DK

Publication Date: 2013-02-21

Variant appearance in text: EGF: G466V

PubMed Link: 23352452

Variant Present in the following documents:

• Main text

View BVdb publication page